What is she best known for?
The fields of study she is best known for:
- Cancer
- Gene
- Internal medicine
Corazon D. Bucana mostly deals with Angiogenesis, Cancer research, Vascular endothelial growth factor, Vascular endothelial growth factor A and Pathology.
Her Angiogenesis research integrates issues from Endothelial stem cell, Basic fibroblast growth factor, Growth factor and Cell growth.
She interconnects Endocrinology, Interleukin 8, Nude mouse, Internal medicine and Metastasis in the investigation of issues within Cancer research.
Her work carried out in the field of Vascular endothelial growth factor brings together such families of science as Tumor suppressor gene, Tyrosine kinase, Growth factor receptor inhibitor and Multiplicity of infection.
Her Vascular endothelial growth factor A research is multidisciplinary, relying on both Tumor progression, Regulation of gene expression, Growth factor receptor and HIF1A.
Her research in Pathology intersects with topics in Immunofluorescence, Brain metastasis and Sensitization.
Her most cited work include:
- Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. (1184 citations)
- Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. (921 citations)
- Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery (588 citations)
What are the main themes of her work throughout her whole career to date?
Corazon D. Bucana spends much of her time researching Cancer research, Pathology, Angiogenesis, Metastasis and Vascular endothelial growth factor.
Her Cancer research research includes elements of Endocrinology, Epidermal growth factor receptor, Internal medicine, Growth factor receptor and In vivo.
Corazon D. Bucana combines subjects such as Cancer, Colorectal cancer and Melanoma with her study of Pathology.
The various areas that she examines in her Angiogenesis study include Endothelial stem cell, Basic fibroblast growth factor, Growth factor and Cell growth.
Corazon D. Bucana usually deals with Metastasis and limits it to topics linked to Cell culture and Molecular biology.
In her study, Receptor tyrosine kinase is inextricably linked to Tyrosine kinase, which falls within the broad field of Vascular endothelial growth factor.
She most often published in these fields:
- Cancer research (42.86%)
- Pathology (37.23%)
- Angiogenesis (29.44%)
What were the highlights of her more recent work (between 2002-2013)?
- Cancer research (42.86%)
- Angiogenesis (29.44%)
- Pathology (37.23%)
In recent papers she was focusing on the following fields of study:
Corazon D. Bucana mostly deals with Cancer research, Angiogenesis, Pathology, Internal medicine and Vascular endothelial growth factor.
Corazon D. Bucana has researched Cancer research in several fields, including Cancer, Growth factor receptor, Pancreatic cancer, Epidermal growth factor receptor and Epidermal growth factor.
Her Angiogenesis study incorporates themes from Endothelial stem cell, Basic fibroblast growth factor, Colorectal cancer and Transfection.
Her studies in Pathology integrate themes in fields like Blood vessel, Cell culture and Metastasis, Brain metastasis.
Her Internal medicine research includes elements of Endocrinology and Oncology.
Corazon D. Bucana does research in Vascular endothelial growth factor, focusing on Vascular endothelial growth factor A specifically.
Between 2002 and 2013, her most popular works were:
- Therapeutic EphA2 Gene Targeting In vivo Using Neutral Liposomal Small Interfering RNA Delivery (588 citations)
- Role of Hypoxia-Inducible Factor 1α in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation (226 citations)
- Inhibition of integrin α5β1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice (189 citations)
In her most recent research, the most cited papers focused on:
Her main research concerns Cancer research, Angiogenesis, Vascular endothelial growth factor, Pancreatic cancer and Growth factor receptor.
Her Cancer research research is multidisciplinary, incorporating perspectives in Pericyte, Epidermal growth factor receptor, Pathology, Colorectal cancer and Adenocarcinoma.
Pathology and Neovascularization are commonly linked in her work.
Her research in Angiogenesis intersects with topics in Endothelial stem cell, Endocrinology and Metastasis.
She has included themes like Epidermal growth factor and Cell growth in her Vascular endothelial growth factor study.
The concepts of her Pancreatic cancer study are interwoven with issues in Platelet-derived growth factor, Growth factor, Platelet-derived growth factor receptor and C-Met.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
